13F Data
13F filer · CIK 1505246

Context Partners Fund, L.P.

LA JOLLA, CA · filing since Q3 2018 · last filing Nov 16, 2020
Reported value
$460.1M
Positions
164
New / sold out
164 / 0
Added / reduced
0 / 0
Turnover
–
buys $460.1M · sells $0
Top-10 weight
27.5%

No 13F for Q2 2020, so every position this quarter shows as new.

Biggest buys vs Q2 2020

ChangeSecurityShares changeChange %Est. trade value
New8X8 INC NEW+20,876,000–+$19.4M
NewSEA LTD+7,000,000–+$13.1M
NewVEONEER INCORPORATED+12,946,000–+$12.8M
NewINTERCEPT PHARMACEUTICALS IN+15,799,000–+$12.7M
NewAMAG PHARMACEUTICALS INC+14,068,000–+$12.6M
NewCF FINANCE ACQUISITION CORP+1,160,000–+$11.6M
NewCHURCHILL CAPITAL CORP IV+890,000–+$11.6M
NewNANTHEALTH INC+12,240,000–+$11.3M
NewINFINERA CORPORATION+11,750,000–+$10.8M
NewPRA GROUP INC+9,800,000–+$10.7M
154 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2020

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2018: $171.9MQ3 2020: $460.1M
Q3 2018Q3 2020

Holdings · Q3 2020

#SecuritySharesValueWeight
18X8 INC NEWNOTE 0.500% 2/020,876,000$19.4M4.22%
2SEA LTDDEBT 2.375%12/07,000,000$13.1M2.84%
3VEONEER INCORPORATEDNOTE 4.000% 6/012,946,000$12.8M2.77%
4INTERCEPT PHARMACEUTICALS INNOTE 3.250% 7/015,799,000$12.7M2.76%
5AMAG PHARMACEUTICALS INCNOTE 3.250% 6/014,068,000$12.6M2.74%
6CHURCHILL CAPITAL CORP IVUNIT 99/99/9999890,000$11.6M2.53%
6CF FINANCE ACQUISITION CORPUNIT 08/01/20271,160,000$11.6M2.53%
8NANTHEALTH INCNOTE 5.500%12/112,240,000$11.3M2.46%
9INFINERA CORPORATIONNOTE 2.125% 9/011,750,000$10.8M2.36%
10PRA GROUP INCNOTE 3.500% 6/09,800,000$10.7M2.33%
154 more rows. Subscribe for $29/month to see every row, download the data and use the API.